In this issue:
- Impact of HCV cure on mortality and morbidity in HIV after ART initiation
- Pitavastatin to prevent CV disease in HIV
- Comorbidities/polypharmacy in minorities: impact on virological suppression in HIV
- Sexual HIV transmission risk with low-level HIV viraemia
- CD4/CD8 ratio according to third active drug class in ART
- Second-line switch to dolutegravir for HIV
- Pregnancy outcomes in women with HIV
- Long-acting ART in a diverse HIV population
- U=U awareness among gay and bisexual men
- Treatment-as-prevention and its effect on HIV incidence
Please login below to download this issue (PDF)